ABBOTT has announced a
massive US$230 million investment
in a new “state of the art nutrition
manufacturing facility” in Jiaxing,
China, representing the company’s
biggest ever Chinese investment.
The growing middle class and
over 17 million babies born each
year in China are creating increased
demand for high-quality nutrition
products, with Abbott saying it
anticipates launching a number of
product innovations over the next
three years across the paediatric
nutrition category.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Aug 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Aug 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.